Increased Bone Mineral Content in Patients with Congenital Generalized Lipodystrophy Is Unaffected By Metreleptin Replacement Therapy

被引：0
|
作者：
Christensen, John D. [1 ]
Lungu, Andreea O. [2 ]
Cochran, Elaine [1 ]
Collins, Michael T. [3 ]
Gafni, Rachel I. [3 ]
Reynolds, James C. [4 ]
Gorden, Phillip [1 ]
Brown, Rebecca J. [1 ]
机构：
[1] NIDDK, NIH, Bethesda, MD USA
[2] Joslin Diabet Ctr, Brookline, MA USA
[3] NIDCR, NIH, Bethesda, MD USA
[4] NIH, Bethesda, MD 20892 USA
来源：
ENDOCRINE REVIEWS | 2014年 / 35卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OR43-6
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Long-term effectiveness and safety of metreleptin in the treatment of patients with generalized lipodystrophy
    Rebecca J. Brown
    Elif A. Oral
    Elaine Cochran
    David Araújo-Vilar
    David B. Savage
    Alison Long
    Gregory Fine
    Taylor Salinardi
    Phillip Gorden
    Endocrine, 2018, 60 : 479 - 489
  • [22] Long-term effectiveness and safety of metreleptin in the treatment of patients with generalized lipodystrophy
    Brown, Rebecca J.
    Oral, Elif A.
    Cochran, Elaine
    Araujo-Vilar, David
    Savage, David B.
    Long, Alison
    Fine, Gregory
    Salinardi, Taylor
    Gorden, Phillip
    ENDOCRINE, 2018, 60 (03) : 479 - 489
  • [23] Effect of leptin replacement on intrahepatic and intramyocellular lipid content in patients with generalized lipodystrophy
    Simha, V
    Szczepaniak, LS
    Garg, A
    DIABETES, 2002, 51 : A89 - A89
  • [24] Effect of leptin replacement on intrahepatic and intramyocellular lipid content in patients with generalized lipodystrophy
    Simha, V
    Szczepaniak, LS
    Wagner, AJ
    DePaoli, AM
    Garg, A
    DIABETES CARE, 2003, 26 (01) : 30 - 35
  • [25] Heterogeneity and high prevalence of bone manifestations, and bone mineral density in congenital generalized lipodystrophy subtypes 1 and 2
    Freire, Erika Bastos Lima
    d'Alva, Catarina Brasil
    Madeira, Mayara Ponte
    Lima, Grayce Ellen da Cruz Paiva
    Fernandes, Virginia Oliveira
    Aguiar, Lindenberg Barbosa
    Portella, Leonardo Barreira
    Ozorio, Renan Galvao
    Ponte, Clarisse Mourao Melo
    Montenegro, Ana Paula Dias Rangel
    Montenegro Junior, Renan Magalhaes
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [26] Sleep Disorders in Patients with Congenital Generalized Lipodystrophy
    Fernandes, Virginia O.
    Silva, Carla P.
    Montenegro, Ana Paula D. R.
    Ponte, Clarisse M. M.
    Batista, Livia A. A.
    Pinto, Thisciane F.
    Vasconcelos, Izabella T.
    Karbage, Lia A. S.
    Fernandes, Priscila M.
    D'Alva, Catarina B.
    Bruin, Pedro F. C.
    Montenegro, Renan M., Jr.
    DIABETES, 2018, 67
  • [27] Intramuscular lipid is increased in subjects with congenital generalized lipodystrophy.
    Stein, DT
    Szczepaniak, L
    Garg, A
    Malloy, C
    McGarry, JD
    DIABETES, 1997, 46 : 929 - 929
  • [28] Facial soft tissue volume decreases during metreleptin treatment in patients with partial and generalized lipodystrophy
    Konstanze Miehle
    Michael Stumvoll
    Mathias Fasshauer
    Thomas Hierl
    Endocrine, 2017, 58 : 262 - 266
  • [29] BONE MINERAL DENSITY IN BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY
    Oliveira-Filho, A.
    Medeiros, P.
    Nunes, A.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 116 - 116
  • [30] Effects of Metreleptin in Patients With Generalized Lipodystrophy Before vs After the Onset of Severe Metabolic Disease
    Brush, Maiah
    Auh, Sungyoung
    Cochran, Elaine
    Tuska, Rebecca
    Koh, Christopher
    Kleiner, David E.
    Lightbourne, Marissa
    Brown, Rebecca J.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024,
12345